We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Osmetech | LSE:OMH | London | Ordinary Share | GB00B0K29R51 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.15 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMOMH RNS Number : 4746A Osmetech PLC 08 October 2009 8 October 2009 Osmetech plc ('Osmetech' or the 'Company') Grant of Warrants and Share Options to Directors The Company, as part of the announcement made on 25 June 2009, notified its intention to award certain share options and warrants to the board. Accordingly, the Company today announces that on 25 September 2009 the following warrants and share options were granted to the following directors. Christopher Gleeson, non-executive chairman of the Company, was granted a total of 50,782,817 warrants over ordinary shares of 0.10p in the Company (the "Warrants"). Of these, 30,469,226 Warrants are exercisable at a price of 2p and 20,312,817 Warrants are exercisable at a price of 3p. All Warrants are exercisable up until the earlier of certain events and 30 June 2012. Christopher Gleeson and Daryl Faulkner, non-executive director of the Company, were each granted 5,768,213 options over ordinary shares of 0.10p in the Company at a price of 2.085p (the "Options"). Christopher Gleeson's Options will vest in three annual tranches with effect from 1 July 2010 and will expire on 24 September 2019. Daryl Faulkner's Options will vest in three annual tranches with effect from 20 January 2010 and will expire on 24 September 2019. Following the grants of the Warrants and Options their total interests in the share capital of the Company are: +------------------------------------+------------------------------------+ | Christopher Gleeson; | | | | | +------------------------------------+------------------------------------+ | Ordinary Shares | - | +------------------------------------+------------------------------------+ | Options over Ordinary Shares | 5,768,213 | +------------------------------------+------------------------------------+ | Warrants over Ordinary Shares | 50,782,043 | | | | +------------------------------------+------------------------------------+ +------------------------------------+------------------------------------+ | Daryl Faulkner: | | | | | +------------------------------------+------------------------------------+ | Ordinary Shares | - | +------------------------------------+------------------------------------+ | Options over Ordinary Shares | 5,768,213 | +------------------------------------+------------------------------------+ Enquiries: +------------------------------------+------------------------------------+ | Osmetech plc | +44 (0) 20 7849 6027 | | David Sandilands, Finance Director | | | | | +------------------------------------+------------------------------------+ | Canaccord Adams Limited | +44 (0) 20 7050 6500 | | Robert Finlay | | | Henry Fitzgerald-O'Connor | | +------------------------------------+------------------------------------+ This information is provided by RNS The company news service from the London Stock Exchange END RDSUUGUGUUPBGPR
1 Year Osmetech Chart |
1 Month Osmetech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions